price month
 close
ep ahead guidanc lack bite
exceed estim better revenu profit lower tax
rate ad rais ep reflect
beat off-set lower revenu temper ep
reflect fx higher tax rate higher
interest tp stand
revenu profit rise revenu match estim robust
organ growth vs estimate vs estimate driven
us ou impress consum vs
estimate stronger instrument sale vs estimate
rise premium placement catalyst sedivu ref lab
aggress view weaker ou contribut
us mid-teen rapid vs estimate still healthi despit new
competit vs estimate strong inher higher
margin unit lpd vs estimate gross margin improv
bp price product improv op expens declin
bp bp plan contribut ebit margin expans bp
bp ahead plan flow million flat growth help fund
million share repurchas reserv stand
reiter outperform idxx share may subsid despit latest
upsid healthi instrument placement lighter oper target
focu organ growth
midpoint shi estim albeit consist
normal experi ep target midpoint
fall short consensu primarili fx factor line
like element conservat earli view still continu view
compel altern healthcar invest strong recur
retent healthi fundament backdrop contribut greater
predict visibl earn growth
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
global leader diagnost point-of-car equip
refer laboratori servic companion anim also
provid system diagnost livestock water qualiti
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
share gain refer laboratori point-of-car acceler
global expans greater contribut innov new product
launch technolog advanc greater expect
growth broader anim health industri fundament
stronger expect macroeconom fx headwind
increasingli global footprint less adoption/tract futur product
launch deterior veterinari health fundament
 close
compani mention price
